[Perspectives of the use of pharmacogenetic tests in neurology and psychiatry].
| Autor: | Kostyuk GP; Alekseev Psychiatric Clinical Hospital #1, Moscow, Russia., Zakharova NV; Alekseev Psychiatric Clinical Hospital #1, Moscow, Russia., Reznik AM; Medical Institute of Ongoing Education of 'Moscow National University of Food Production', Moscow, Russia., Surkova EI; Genotek, Ltd, Moscow, Russia., Ilinsky VV; Genotek, Ltd, Moscow, Russia. |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2019; Vol. 119 (9), pp. 131-135. |
| DOI: | 10.17116/jnevro2019119091131 |
| Abstrakt: | The review is devoted to the analysis of the current state of pharmacogenetic research and their use in psychiatric practice. The main genes responsible for the pharmacodynamics and pharmacokinetics of drugs used in psychiatry are listed. Foreign pharmacogenetic clinical recommendations and progress on their implementation in medical practice in various countries of Europe and the USA are analyzed. The need to create Russian clinical guidelines on pharmacogenomics to improve the effectiveness of patient care and to implement a personalized approach to therapy is discussed. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|